Audrey Hutter is a business development director for Greiner BioOne. She was VP for Global Marketing and Investor Relations at Aastrom, the Ann Arbor based stem cell therapeutics company.

Dr. Eliason has worked in stem cell research for over 40 years at institutions around the world. Dr. Eliason received his Ph.D. in biochemistry from the University of Chicago. He has worked at Roche in Basel, Switzerland and Kamakura, Japan. He was a founder and CSO of Asterand, the human tissue research services company. He is Director of the Great Lakes Stem Cell Innovation Center and is adjunct faculty at the Karmanos Cancer Institute.

Ms Eason-Butler is a cell culture specialist and has worked with a variety of different stem cell cultures at Velcura and Asterand.

Mr. Landesman has vast experience in financial matters for large companies as well as start-ups. He is the author of "Corporate Financial Management. Strategies for Maximizing Shareholder Wealth".